Law and policy director Gail Javitt presents comments at the Food and Drug Administration hearing on Consumer-Directed Promotion of Regulated Medical Products
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.